Latest Market News

Singular Health Group has advanced its US expansion through the deployment of 3DICOM™ licenses under a key contract with Provider Network Solutions, alongside appointing a new US commercial chief to drive growth.

Australian Strategic Materials secures A$50.8 million via share placement to fund Korean plant expansion and advance US metals project, while navigating complex supply chain and funding risks.

ASM Limited has raised A$55 million to accelerate production capacity at its Korean Metals Plant and expand its footprint in the rare earths sector, responding to growing global demand and geopolitical supply chain pressures.

Kinetiko Energy reports sustained strong gas flows from two production wells in South Africa, with high methane content exceeding prior reserve assumptions. These results bolster the economics of its planned micro LNG pilot project.

Raiz Invest has hit a record $2 billion in funds under management, driven by strong customer growth and innovative product launches. The fintech’s latest quarter also saw strategic partnerships expand its market reach.

Asian Battery Metals PLC has successfully raised $6 million through an oversubscribed equity placement, positioning the company to advance exploration and acquisition efforts across its Mongolian battery metals projects.

True North Copper has appointed Andrew Mooney as Managing Director, signaling a strategic shift towards advanced exploration and project development in Queensland.

Horizon Minerals reported steady gold production from Boorara and Phillips Find, unveiled promising high-grade drilling results at Burbanks, and acquired the Gordons Project near Black Swan, while progressing a key Pre-Feasibility Study for a gold processing plant conversion.

AdAlta Limited has raised up to A$1.1 million through a private placement, boosting its war chest to advance innovative cellular immunotherapy projects targeting solid cancers.

Love Group Global Ltd reports a modest rise in quarterly cash receipts and operating cash flow, driven by a rebound in Hong Kong, while Singapore lags. The company signals early moves toward US and UK expansion.

Neuren Pharmaceuticals has secured FDA Fast Track designation for its drug NNZ-2591 targeting Phelan-McDermid syndrome, accelerating its path through clinical development. This milestone underscores the urgent need for treatments in rare neurodevelopmental disorders.

Horizon Gold advances its Gum Creek project with significant gold intercepts from water bore drilling and launches an AI-powered exploration platform, while maintaining its feasibility study timeline and securing $12 million in fresh capital.